Ignite Creation Date:
2024-05-05 @ 12:07 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00240253
Status:
COMPLETED
Last Update Posted:
2015-03-31
First Post:
2005-10-14
Brief Title:
A Study Evaluating the Efficacy and Safety of Adding Symlin to Lantus Insulin Glargine in Subjects With Type 2 Diabetes
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2006-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-06
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-14
First Submit QC Date:
October 14 2005
Study First Post Date:
2005-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-03-26
Last Update Post Date:
2015-03-31
Last Update Post Date Type:
ESTIMATED